Back to ALKSAlkermes plc (ALKS)View Full Landscape
intensive diabetes management starting with an adjusted dose of Human Insulin Inhalation Powder
Phase 3Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
13 competitors in Diabetes Mellitus, Type 2
LLYDetemir
Phase 3NVOInsulin Icodec
Phase 3LLYHuman Insulin Inhalation Powder
Phase 3LLYInsulin lispro mix 25
Phase 3NVOInsulin Glargine 100U/mL
Phase 3Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts